BMS Veteran Luisa Salter-Sid Named Gossamer Chief Scientific Officer

Xconomy San Diego — 

Luisa Salter-Cid has joined Gossamer Bio as the San Diego company’s chief scientific officer. Salter-Cid comes to Gossamer from Bristol-Myers Squibb (NYSE: BMY), where she held various positions over the past 13 years, including vice president and head of immunology, small molecule immuno-oncology, and genomics discovery. Gossamer formed in January to in-license and develop drugs for various diseases. In July, the company raised $230 million in a Series B round of financing.